Meeting
2023 ASCO Annual Meeting
Women with pathogenic variants in moderate penetrance breast cancer genes: How frequently do they meet high penetrance genetic testing criteria?
Authors
Nicole Casasanta
Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
Nicole Casasanta , Emily R. Soper , Noura S. Abul-Husn
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Hereditary Cancer Syndromes
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10584)
DOI
10.1200/JCO.2023.41.16_suppl.10584
Abstract #
10584
Poster Bd #
217
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Expanded yield of multiplex panel testing in fully accrued prospective trial.
First Author: Gregory Idos
Poster
2022 ASCO Genitourinary Cancers Symposium
Putative germline findings in tumor-only and liquid biopsy sequencing in veterans with aggressive prostate cancer.
First Author: Kara Noelle Maxwell
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Germline pathogenic variants among Mexican patients with adenocarcinoma of the pancreas.
First Author: Jose Luis Rodriguez Olivares
Poster
2017 ASCO Annual Meeting
Safety of multiplex gene testing for inherited cancer risk in a fully accrued prospective trial.
First Author: Allison W. Kurian